Minimum risk weights for comparing treatments in stratified binomial trials.

Area of Science:

• Biostatistics
• Clinical Trials
• Statistical Methods

Background:

• Stratified trials with binary endpoints commonly use weighted averaging for analysis.
• Current methods often employ harmonic means of sample sizes (SSIZE) or inverse variances (INVAR) for weighting.
• The choice between SSIZE and INVAR can lead to inefficient analyses.

Purpose of the Study:

• To introduce a novel 'minimum risk' (MR) weighting strategy for stratified trials.
• To demonstrate the advantages of MR weights over SSIZE and INVAR in terms of precision and bias.
• To evaluate the statistical power and efficiency of the MR weighting strategy.

Main Methods:

• Development of the 'minimum risk' (MR) weighting formula.
• Comparative analysis using a simulation study.
• Evaluation of bias, precision, and statistical power.

Main Results:

• The MR weighting strategy provides more precise and less biased estimates compared to SSIZE and INVAR.
• Simulation results indicate that MR weights offer an attractive compromise in statistical power.
• The proposed MR weights enhance the efficiency of data analysis in stratified trials.

Conclusions:

• The 'minimum risk' (MR) weighting strategy is a superior alternative for analyzing stratified trials with binary endpoints.
• MR weights improve the accuracy and efficiency of treatment effect estimation.
• This method offers a practical solution to the problem of suboptimal weight selection in clinical trial analysis.